Overview
- 3 public-safe observations are available for this inspection.
- 3 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
14 Sep 2023
21 CFR 50.52
Factors required for approval
Cited by Dana M Klimavicz, Christopher M Jeffers
14 Sep 2023
21 CFR 56.108(b)(2)
Prompt reporting of noncompliance
Cited by Dana M Klimavicz, Christopher M Jeffers
14 Sep 2023
21 CFR 56.115(a)(2)
Minutes of IRB meetings
Cited by Dana M Klimavicz, Christopher M Jeffers
Inspected site
BRBaton Rouge General Medical Center IRBBaton Rouge, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 50.52 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 56.108(b)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 56.115(a)(2) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 3 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere